blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1503786

EP1503786 - A METHOD OF INHIBITING THE EMIGRATION OF CELLS FROM THE INTRAVASCULAR COMPARTMENT INTO TISSUES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  29.05.2009
Database last updated on 11.09.2024
Most recent event   Tooltip29.05.2009Application deemed to be withdrawnpublished on 01.07.2009  [2009/27]
Applicant(s)For all designated states
IPF Pharmaceuticals GmbH
Feodor-Lynen-Str. 31
30625 Hannover / DE
[2005/06]
Inventor(s)01 / FORSSMANN, Ulf, IPF PharmaCeuticals GmbH
Feodor-Lynen-Str. 31
30625 Hannover / DE
02 / ELSNER, Jörn
Lister Meile 57
D-30161 Hannover / DE
03 / ESCHER, Sylvia
Fundstr. 8
D-30161 Hannover / DE
04 / SPODSBERG, Nikolaj
Nonnetofte Alle 7
DK-2500 Copenhagen / DK
 [2005/15]
Former [2005/06]01 / FORSSMANN, Ulf, IPF PharmaCeuticals GmbH
Feodor-Lynen-Str. 31
30625 Hannover / DE
02 / ELSNER, Jörn
Pickertsberg 35
D-31515 Wunstorf / DE
03 / ESCHER, Sylvia
Liebigstr. 6
D-30163 Hannover / DE
04 / SPODSBERG, Nikolaj
Rautenstr. 20
D-30171 Hannover / DE
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[N/P]
Former [2005/06]von Kreisler Selting Werner
Patentanwälte P.O. Box 10 22 41
50462 Köln / DE
Application number, filing date03729998.909.05.2003
[2005/06]
WO2003EP04872
Priority number, dateEP2002001057310.05.2002         Original published format: EP 02010573
EP2002001120121.05.2002         Original published format: EP 02011201
US20020381802P21.05.2002         Original published format: US 381802 P
[2005/06]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03094950
Date:20.11.2003
Language:EN
[2003/47]
Type: A2 Application without search report 
No.:EP1503786
Date:09.02.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 20.11.2003 takes the place of the publication of the European patent application.
[2005/06]
Search report(s)International search report - published on:EP26.02.2004
ClassificationIPC:A61K38/19, A61K38/17, A61K38/07, A61K31/557, A61P37/06, A61P29/00
[2005/06]
CPC:
A61K38/195 (EP,US); A61K31/00 (EP,US); A61K31/557 (EP,US);
A61P29/00 (EP); A61P37/06 (EP)
Designated contracting statesDE,   ES,   FR,   GB,   IT [2005/35]
Former [2005/06]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:METHODE ZUR HEMMUNG DER EMIGRATION VON ZELLEN AUS DEM INTRAVASKULÄREN KOMPARTIMENT INS GEWEBE[2005/06]
English:A METHOD OF INHIBITING THE EMIGRATION OF CELLS FROM THE INTRAVASCULAR COMPARTMENT INTO TISSUES[2005/06]
French:PROCEDE VISANT A INHIBER L'EMIGRATION DES CELLULES DU COMPARTIMENT INTRAVASCULAIRE DANS LES TISSUS[2005/06]
Entry into regional phase16.10.2004National basic fee paid 
16.10.2004Designation fee(s) paid 
16.10.2004Examination fee paid 
Examination procedure10.12.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
16.10.2004Examination requested  [2005/06]
06.06.2006Despatch of a communication from the examining division (Time limit: M06)
13.12.2006Reply to a communication from the examining division
19.06.2008Despatch of a communication from the examining division (Time limit: M06)
30.12.2008Application deemed to be withdrawn, date of legal effect  [2009/27]
04.02.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/27]
Fees paidRenewal fee
27.05.2005Renewal fee patent year 03
30.03.2006Renewal fee patent year 04
30.05.2007Renewal fee patent year 05
27.03.2008Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]EP1167527  (EUROSCREEN SA [BE], et al) [X] 1-16 * abstract * * paragraph [0015] * * paragraph [0041] * * paragraph [0061] * * claims 1-6,20-22 * [Y] 1-16;
 [Y]  - DETHEUX M ET AL, "Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties.", THE JOURNAL OF EXPERIMENTAL MEDICINE. UNITED STATES 20 NOV 2000, (20001120), vol. 192, no. 10, ISSN 0022-1007, pages 1501 - 1508, XP002241991 [Y] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1084/jem.192.10.1501
 [Y]  - MUENCH JAN ET AL, "Hemofiltrate CC chemokine 1(9-74) causes effective internalization of CCR5 and is a potent inhibitor of R5-tropic human immunodeficiency virus type 1 strains in primary T cells and macrophages.", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, April, 2002, (200204), vol. 46, no. 4, ISSN 0066-4804, pages 982 - 990, XP002241992 [Y] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1128/AAC.46.4.982-990.2002
 [A]  - TERAN L M, "CCL Chemokines and asthma", IMMUNOLOGY TODAY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, (200005), vol. 21, no. 5, ISSN 0167-5699, pages 235 - 242, XP004198153 [A] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0167-5699(00)01634-0
Examination   - MOSIER-DE ET AL., "Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants", JOURNAL OR VIROLOGY, (199905), page 3544-3550
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.